Reports from neuropathic pain and Alzheimer’s disease (AD) models have further shown that there may be differential signaling elicited by full-length vs soluble FKN [14–16]. The gene discussed is CX3CL1; the disease is early-onset autosomal dominant Alzheimer disease.